These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 30872175)
1. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database. Zhai H; Li D; Feng Q; Qian X; Li L; Yao J Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175 [TBL] [Abstract][Full Text] [Related]
2. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality. Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556 [TBL] [Abstract][Full Text] [Related]
3. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. Martin JA; Warner RR; Wisnivesky JP; Kim MK Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors. Shi M; Zhou B Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476 [TBL] [Abstract][Full Text] [Related]
5. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Kuo EJ; Salem RR Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245 [TBL] [Abstract][Full Text] [Related]
6. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study. Cai JS; Chen HY; Lu YF; Yu RS Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701 [No Abstract] [Full Text] [Related]
7. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors. Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190 [TBL] [Abstract][Full Text] [Related]
9. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors. Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study. Yadav S; Sharma P; Zakalik D Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698 [TBL] [Abstract][Full Text] [Related]
11. Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors. Chen HY; Zhou YL; Chen YH; Wang X; Zhang H; Ke NW; Liu XB; Tan CL World J Gastroenterol; 2020 Jul; 26(25):3638-3649. PubMed ID: 32742132 [TBL] [Abstract][Full Text] [Related]
12. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior. Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis. Li X; Gou S; Liu Z; Ye Z; Wang C Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547 [TBL] [Abstract][Full Text] [Related]
14. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems. Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952 [TBL] [Abstract][Full Text] [Related]
15. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database. Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275 [TBL] [Abstract][Full Text] [Related]
16. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study. Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Validity of the American Joint Committee on Cancer Eighth Edition TNM Staging System for Surgically Treated and Well-Differentiated Pancreatic Neuroendocrine Tumors: A Comprehensive Analysis of 254 Consecutive Patients From a Large Chinese Institution. Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB Pancreas; 2019; 48(5):613-621. PubMed ID: 31091206 [TBL] [Abstract][Full Text] [Related]
18. Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution. Yang M; Tan CL; Zhang Y; Ke NW; Zeng L; Li A; Zhang H; Xiong JJ; Guo ZH; Tian BL; Liu XB Medicine (Baltimore); 2016 Jul; 95(28):e4213. PubMed ID: 27428224 [TBL] [Abstract][Full Text] [Related]
19. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres. Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]